{"transactions":[{"id":775354,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrants (Right to Buy)","published_at":"2026-05-18T07:46:20.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":12805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 12,805 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 12,805 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":0,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":12805},"source":{"system":"sec-edgar","filing":"0001193125-26-227910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526227910/ownership.xml","form_type":"4"}},{"id":775353,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-18T07:46:20.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":12805,"price":1.0846,"value":13888.303,"ownership":{"direct":true},"balance_after":93366,"source":{"system":"sec-edgar","filing":"0001193125-26-227910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526227910/ownership.xml","form_type":"4"}},{"id":782840,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-12T21:36:39.000Z","date":"2026-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":968,"price":6.85,"value":6630.8,"ownership":{"direct":true},"balance_after":80561,"source":{"system":"sec-edgar","filing":"0001193125-26-219935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526219935/ownership.xml","form_type":"4"}},{"id":930158,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-27T21:11:08.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":593,"price":4.15,"value":2460.95,"ownership":{"direct":true},"balance_after":81529,"source":{"system":"sec-edgar","filing":"0001193125-26-024424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526024424/ownership.xml","form_type":"4"}},{"id":940156,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T21:55:10.000Z","date":"2026-01-10","kind":"grant","planned":false,"acquired":true,"shares":351400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 351,400 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2027, with the remaining three quarters vesting in equal monthly installments through January 10, 2030, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":351400,"derivative":{"exercise_price":4.75,"expiration_date":"2036-01-10","underlying":"Common Stock","underlying_shares":351400},"source":{"system":"sec-edgar","filing":"0001193125-26-011860","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526011860/ownership.xml","form_type":"4"}},{"id":940155,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-13T21:55:10.000Z","date":"2026-01-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4153,"price":4.75,"value":19726.75,"ownership":{"direct":true},"balance_after":82122,"source":{"system":"sec-edgar","filing":"0001193125-26-011860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312526011860/ownership.xml","form_type":"4"}},{"id":1054688,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrants (Right to Buy)","published_at":"2025-08-27T10:30:07.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":12805,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 12,805 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 12,805 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 12,805 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 12,805 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":12805,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":12805},"source":{"system":"sec-edgar","filing":"0001193125-25-189086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312525189086/ownership.xml","form_type":"4"}},{"id":1054687,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-27T10:30:07.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":12805,"price":0.8677,"value":11110.8985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 12,805 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 12,805 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 12,805 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 12,805 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."}],"balance_after":86275,"source":{"system":"sec-edgar","filing":"0001193125-25-189086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000119312525189086/ownership.xml","form_type":"4"}},{"id":1293240,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-28T23:02:04.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 177,000 shares of the Issuer's common stock, one quarter of which will vest on January 28, 2026, with the remaining three quarters vesting in equal monthly installments through January 28, 2029, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":177000,"derivative":{"exercise_price":1.18,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":177000},"source":{"system":"sec-edgar","filing":"0000950170-25-010001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017025010001/ownership.xml","form_type":"4"}},{"id":1517765,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-14T20:02:13.000Z","date":"2024-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":967,"price":10.42,"value":10076.14,"ownership":{"direct":true},"balance_after":73470,"source":{"system":"sec-edgar","filing":"0000950170-24-059492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024059492/ownership.xml","form_type":"4"}},{"id":1587216,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"exercise","planned":true,"acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027."}],"balance_after":17391,"derivative":{"exercise_price":3.57,"expiration_date":"2033-01-25","underlying":"Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587215,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"exercise","planned":true,"acquired":false,"shares":4650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024."}],"balance_after":9300,"derivative":{"exercise_price":3.51,"expiration_date":"2032-09-08","underlying":"Common Stock","underlying_shares":4650},"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587214,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"sale","planned":true,"acquired":false,"shares":4895,"price":10.53,"value":51544.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."}],"balance_after":74437,"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587213,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"sale","planned":true,"acquired":false,"shares":6459,"price":10.53,"value":68013.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."}],"balance_after":79332,"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587212,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"exercise","planned":true,"acquired":true,"shares":6459,"price":3.57,"value":23058.63,"ownership":{"direct":true},"balance_after":85791,"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587211,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"sale","planned":true,"acquired":false,"shares":4650,"price":10.53,"value":48964.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023."}],"balance_after":79332,"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1587210,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-08T22:40:40.000Z","date":"2024-03-06","kind":"exercise","planned":true,"acquired":true,"shares":4650,"price":3.51,"value":16321.5,"ownership":{"direct":true},"balance_after":83982,"source":{"system":"sec-edgar","filing":"0000950170-24-028811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024028811/ownership.xml","form_type":"4"}},{"id":1665383,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-31T21:05:38.000Z","date":"2024-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":593,"price":9.99,"value":5924.07,"ownership":{"direct":true},"balance_after":79332,"source":{"system":"sec-edgar","filing":"0000950170-24-009381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024009381/ownership.xml","form_type":"4"}},{"id":1679241,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-16T21:40:12.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":98100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 98,100 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":98100,"derivative":{"exercise_price":10.09,"expiration_date":"2034-01-10","underlying":"Common Stock","underlying_shares":98100},"source":{"system":"sec-edgar","filing":"0000950170-24-004665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024004665/ownership.xml","form_type":"4"}},{"id":1679240,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-16T21:40:12.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":49050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 49,050 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":79925,"source":{"system":"sec-edgar","filing":"0000950170-24-004665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017024004665/ownership.xml","form_type":"4"}},{"id":1895336,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T20:11:35.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":31800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 31,800 shares of the Issuer's common stock, one quarter of which will vest on May 10, 2024, with the remaining three quarters vesting in equal monthly installments through May 10, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":31800,"derivative":{"exercise_price":2.79,"expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":31800},"source":{"system":"sec-edgar","filing":"0000950170-23-021768","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017023021768/ownership.xml","form_type":"4"}},{"id":1895335,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":46510,"kind":"person","name":"Stout Stephen","position":1,"cik":"0001970664","reported_name":"Stout Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-12T20:11:35.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":15900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 15,900 restricted stock units, which will vest in four equal annual installments beginning on May 10, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":30875,"source":{"system":"sec-edgar","filing":"0000950170-23-021768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1970664/000095017023021768/ownership.xml","form_type":"4"}}]}